Description
SPRINGER Vaccine Design Methods And Protocols Volume 3 Resources For Vaccine Development 2Ed (Hb 2022) by THOMAS S.
This volume provides a practical guide providing step-by-step methods and protocols on vaccine development and production. Divided into three volumes, Volume 3: Resources for Vaccine Development guides readers through chapters on vaccine adjuvants, vaccine vectors, production, vaccine delivery systems, vaccine bioinformatics, vaccine regulation, and intellectual property. Written in the format of the highly successful Methods in Molecular Biology series, each chapter includes an introduction to the topic, lists necessary materials and reagents, includes tips on troubleshooting and known pitfalls, and step-by-step, readily reproducible protocols.Authoritative and practical, Vaccine Design: Methods and Protocols, Second Edition, Volume 3: Resources for Vaccine Development aims to be a useful practical guide to researchers to help further their study in this field. PART I TRENDS IN VACCINE DEVELOPMENT1. Artificial Intelligence for Vaccine DesignPeter McCaffrey2. Progress in the Development of Structure-Based VaccinesSunil Thomas and Ann Abraham3. Polymer-Peptide Conjugate Vaccine for Oral ImmunizationMohammad Omer Faruck, Mariusz Skwarczynski, and Istvan Toth4. An update on "Reverse Vaccinology": The Pathway from Genomes and Epitope Predictions to Tailored, Recombinant VaccinesMarcin Michalik, Bardya Djahanshiri, Jack C. Leo, and Dirk LinkePART II VACCINE VECTORS AND PRODUCTION SYSTEM5. Phage T7 as a Potential Platform for Vaccine DevelopmentChuan Loo Wong, Chean Yeah Yong and Khai Wooi Lee6. Plant-based Systems for Vaccine ProductionMattia Santoni, Elisa Gecchele, Roberta Zampieri, and Linda Avesani7. Production of a Hepatitis E Vaccine Candidate Using the Pichia pastoris Expression SystemJyoti Gupta, Amit Kumar, and Milan SurjitPART III VACCINE ADJUVANTS8. Developments in Vaccine AdjuvantsFarrhana Ziana Firdaus, Mariusz Skwarczynski, and Istvan Toth9. Adjuvants: Engineering Protective Immune Responses in Human and Veterinary VaccinesBassel Akache, Felicity C. Stark, Gerard Agbayani, Tyler M. Renner and Michael J. McCluskie10. Cationic Nanostructures as Adjuvants for Vaccines Ana Maria Carmona-Ribeiro, Beatriz Ideriha Mathiazzi, and Yunys Perez-Betancourt11. Emulsion Adjuvants for Use in Veterinary VaccinesRachel Madera, Yulia Burakova, and Jishu Shi12. Generation of a Liposomal Vaccine Adjuvant Based on Sulfated S-lactosylarchaeol (SLA) GlycolipidsBassel Akache, Yimei Jia, Vandana Chandan, Lise Deschatelets and Michael J. McCluskie13. Glucan particles: choosing the appropriate size to use as a vaccine adjuvantMariana Colaco, Joao Panao Costa, and Olga BorgesPART IV VACCINE DELIVERY SYSTEMS 14. Use of Optical In Vivo Imaging to Monitor and Optimize Delivery of Novel Plasmid-Launched Live-Attenuated VaccinesSapna Sharma and Kai Dallmeier15. Liposomes for the Delivery of Lipopeptide VaccinesJieru Yang, Armira Azuar, Istvan Toth, and Mariusz Skwarczynski16. Current Prospects in Peptide-Based Subunit NanovaccinesPrashamsa Koirala, Sahra Bashiri, Istvan Toth, and Mariusz Skwarczynski17. Design and Synthesis of Protein-based Nanocapsule VaccinesIvana Skakic, Jasmine. E. Francis, and Peter. M. Smooker18. Design and Preparation of Solid Lipid Nanoparticle (SLN) Mediated DNA VaccinesJasmine. E. Francis, Ivana Skakic, and Peter. M. Smooker19. Nano-Particulate Platforms for Vaccine Delivery to Enhance Antigen-Specific CD8+ T Cell ResponseJhanvi Sharma, Carcia S. Carson, Trevor Douglas, John T. Wilson, and Sebastian Joyce20. PilVax: A Novel Platform for the Development of Mucosal VaccinesCatherine (Jia-Yun) Tsai, Jacelyn M.S. Loh, and Thomas ProftPART V VACCINE BIOINFORMATICS21. Bioinformatic Techniques for Vaccine Development: Epitope Prediction and Structural VaccinologyPeter McCaffrey22. Immunoinformatic Approaches for Vaccine Designing for Pathogens with Unclear PathogenesisNaina Arora, Anand K. Keshri, Rimanpreet Kaur, Suraj Singh Rawat, and Amit Prasad23. In silico Identification of the B-cell and T-cell Epitopes of the Antigenic Proteins of Staphylococcus aureus for Potential VaccinesSunil Thomas and Irini Doytchinova24. Computational Mining and Characterization of Hypothetical Proteins of Mycobacterium Bovis towards the Identification of Probable Vaccine CandidatesBhaskar Ganguly25. Recombinant Vaccine Design against Clostridium Spp. Toxins using Immunoinformatics ToolsRafael Rodrigues Rodrigues, Marcos Roberto Alves Ferreira, Frederico Schmitt Kremer, Rafael Amaral Donassolo, Clovis Moreira Junior, Mariliana Luiza Ferreira Alves, and Fabricio Rochedo Conceicao26. Searching Epitope-based Vaccines Using Bioinformatic StudiesMarlet Martinez-Archundia, G Lizbeth Ramirez-Salinas, Jazmin Garcia-Machorroand Jose Correa-BasurtoPART VI VACCINE SAFETY AND REGULATION27. The Regulatory Evaluation of Vaccines for Human UseNorman W. BaylorPART VII VACCINE INTELLECTUAL PROPERTY28. Intellectual Property Rights and VaccinesPenny Gilbert, Richard Fawcett, Joel Coles, and William Hillson29. Vaccine Intellectual PropertyAna Santos Rutschman, Joshua D. Sarnoff, and Timothy L. WiemkenPART VIII PATHWAYS TO VACCINE COMMERCIALIZATION30. Resources for Starting a CompanyAnn Abraham, Jude Mathew, and Sunil Thomas